News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MOYES JAY M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 22,000 shares
@ $3.4532, valued at
$76k
Granted 27,000 shares
@ $0 |
|
| 06/07/2023 |
4
| MOYES JAY M (CFO) has filed a Form 4 on SERA PROGNOSTICS, INC. |
| 03/07/2023 |
4
| MOYES JAY M (CFO) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Granted 32,800 shares
@ $0
Granted 51,800 options to buy
@ $3.8, valued at
$196.8k
|
|
| 09/30/2022 |
4
| MOYES JAY M (Director) has filed a Form 4 on BioCardia, Inc.|
Txns:
| Granted 12,434 options to buy
@ $1.44, valued at
$17.9k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2022 |
4
| MOYES JAY M (CFO) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Granted 168,275 options to buy
@ $3.75, valued at
$631k
|
|
| 07/21/2021 |
4
| MOYES JAY M (CFO) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Converted 2,455 shares
@ $0
Converted 375 shares
@ $0
Converted 2,455 preferred shares
@ $0
Converted 375 preferred shares
@ $0 |
|
| 07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 9,703 shares
@ $10, valued at
$97k
|
|
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 9,720 shares
@ $9.5, valued at
$92.3k
|
|
| 06/11/2020 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 25,748 shares
@ $0 |
|
| 05/20/2020 |
4
| MOYES JAY M (Director) has filed a Form 4 on BioCardia, Inc.|
Txns:
| Granted 8,800 shares
@ $0 |
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2019 |
4
| MOYES JAY M (Director) has filed a Form 4 on BioCardia, Inc.|
Txns:
| Exercised 3,594 restricted stock units
@ $0 |
|
| 06/12/2019 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 19,423 shares
@ $0 |
|
| 05/15/2019 |
4
| MOYES JAY M (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.|
Txns:
| Granted 7,000 options to buy
@ $4.02, valued at
$28.1k
|
|
| 04/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/26/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2018 |
4
| MOYES JAY M (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.|
Txns:
| Granted 12,000 options to buy
@ $2.56, valued at
$30.7k
|
|
| 06/14/2018 |
4
| MOYES JAY M (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 5,822 shares
@ $0 |
|
| 09/12/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|